[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 11 of about 11
1. Cherian MG, Jayasurya A, Bay BH: Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res; 2003 Dec 10;533(1-2):201-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Metallothioneins (MT) are a group of low-molecular weight, cysteine rich intracellular proteins, which are encoded by a family of genes containing at least 10 functional isoforms in human.
  • The expression and induction of these proteins have been associated with protection against DNA damage, oxidative stress and apoptosis.
  • A number of studies have shown an increased expression of MT in various human tumors of the breast, colon, kidney, liver, lung, nasopharynx, ovary, prostate, salivary gland, testes, thyroid and urinary bladder.
  • However, MT is down-regulated in certain tumors such as hepatocellular carcinoma and liver adenocarcinoma.
  • Some of the evidence supporting a role for MT in both intrinsic and acquired drug resistance is critically evaluated in this review.
  • Therefore, additional experimental data on MT and its isoforms in human tumors, are needed to elucidate the biological functions of MT during tumor progression, along with other tumor markers.
  • [MeSH-minor] Drug Resistance, Neoplasm. Humans. Metals / metabolism. Protein Isoforms / metabolism

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 14643421.001).
  • [ISSN] 0027-5107
  • [Journal-full-title] Mutation research
  • [ISO-abbreviation] Mutat. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Metals; 0 / Protein Isoforms; 9038-94-2 / Metallothionein
  • [Number-of-references] 64
  •  go-up   go-down


2. Izydore RA, Zhang Y, Zhou X, Warren AE, Wheaton JR, Hall IH: The cytotoxicity of 1-(1-phenylalkylideneamino)-2,4-azetidinediones and their mode of action in human and murine tumor cells. Anticancer Res; 2001 Jan-Feb;21(1A):157-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The 1-(1-phenylalkylideneamino)-2,4-azetidinediones are potent cytotoxic agents against the growth of human and murine leukemias, lymphoma, and suspended HeLa uterine carcinoma.
  • In cell lines cultured from solid human tumors, the agents were more selective with only a few agents demonstrating significant activity against the growth of HCT-8 ileum adenocarcinoma, Saos-2 osteosarcoma, KB nasopharynx, MCF-7 breast effusion, and ovary 1-A9 carcinoma A mode of action study in murine L1210 lymphoid leukemia cells showed that the agents inhibited DNA and RNA syntheses after 60 min.
  • The compounds were potent inhibitors of the de novo purine synthesis suppressing the activity of both regulatory enzymes of the pathway, i.e., PRPP-amido transferase and IMP dehydrogenase.
  • In addition, the agents reduced the activity of ribonucleotide reductase, dihydrofolate reductase, RNA polymerases, and thymidine kinases as well as the reduction of d[NTP] pools.
  • The DNA molecule itself was not a target for the agents in that alkylation of nucleoide bases, intercalation between base pairs, and cross-linking of DNA strands did not occur.
  • [MeSH-major] Antimetabolites, Antineoplastic / pharmacology. Azetidines / pharmacology. Leukemia L1210 / drug therapy
  • [MeSH-minor] Animals. DNA Replication / drug effects. Drug Screening Assays, Antitumor. HL-60 Cells. HeLa Cells. Humans. Mice. Purines / metabolism. Transcription, Genetic / drug effects. Tumor Cells, Cultured

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11299729.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Azetidines; 0 / Purines
  •  go-up   go-down


3. Wang YH, Hou AJ, Chen L, Chen DF, Sun HD, Zhao QS, Bastow KF, Nakanish Y, Wang XH, Lee KH: New isoprenylated flavones, artochamins A--E, and cytotoxic principles from Artocarpus chama. J Nat Prod; 2004 May;67(5):757-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Artonin E (12) showed strong cytotoxicity against 1A9 (ovarian), significant activity against MCF-7 (breast adenocarcinoma), and moderate activity against HCT-8 (ileocecal) and MDA-MB-231 (breast adenocarcinoma) tumor cell lines.
  • Artochamin C (3) was more potent against MCF-7, 1A9, HCT-8, and SK-MEL-2 (melanoma) than A549 (lung carcinoma), KB (epidermoid carcinoma of the nasopharynx), and its drug-resistant (KB-VIN) variant.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / isolation & purification. Artocarpus / chemistry. Drugs, Chinese Herbal / isolation & purification. Flavonoids / isolation & purification. Plants, Medicinal / chemistry
  • [MeSH-minor] Drug Resistance, Neoplasm / drug effects. Drug Screening Assays, Antitumor. Humans. Molecular Structure. Plant Roots / chemistry. Tumor Cells, Cultured

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15165133.001).
  • [ISSN] 0163-3864
  • [Journal-full-title] Journal of natural products
  • [ISO-abbreviation] J. Nat. Prod.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 17625
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Drugs, Chinese Herbal; 0 / Flavonoids
  •  go-up   go-down


Advertisement
4. Ismail N, Alam M: A novel cytotoxic flavonoid glycoside from Physalis angulata. Fitoterapia; 2001 Aug;72(6):676-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Compound 1 showed remarkable cytotoxicity in vitro against murine leukemia cell line P-388, epidermoid carcinoma of the nasopharynx KB-16 cells, and lung adenocarcinoma A-549 with ED(50) values of 0.048, 0.50 and 0.55 microg ml(-1), respectively.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / pharmacology. Flavonoids / pharmacology. Glycosides / pharmacology. Phytotherapy. Plant Extracts / pharmacology. Solanaceae
  • [MeSH-minor] Animals. Humans. Inhibitory Concentration 50. KB Cells / drug effects. Mice. Plant Leaves. Tumor Cells, Cultured / drug effects

  • MedlinePlus Health Information. consumer health - Herbal Medicine.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11543968.001).
  • [ISSN] 0367-326X
  • [Journal-full-title] Fitoterapia
  • [ISO-abbreviation] Fitoterapia
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Flavonoids; 0 / Glycosides; 0 / Plant Extracts; 0 / myricetin 3-O-neohesperidoside
  •  go-up   go-down


5. Wang Q, Chen TH, Bastow KF, Lee KH, Chen DF: Altaicalarins A-D, cytotoxic bisabolane sesquiterpenes from Ligularia altaica. J Nat Prod; 2010 Feb 26;73(2):139-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The isolated compounds were also evaluated for cytotoxic activity against human lung carcinoma (A-549), human breast adenocarcinoma (MCF-7), epidermoid carcinoma of the nasopharynx (KB), and vincristine-resistant nasopharyngeal (KBVIN) cell lines, and 1 was found to show significant cytotoxicity, with EC(50) values of 3.4, 0.8, 1.0, and 0.9 microg/mL, respectively.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / isolation & purification. Antineoplastic Agents, Phytogenic / pharmacology. Asteraceae / chemistry. Sesquiterpenes / isolation & purification. Sesquiterpenes / pharmacology
  • [MeSH-minor] Crystallography, X-Ray. Drug Resistance, Neoplasm / drug effects. Drug Screening Assays, Antitumor. Drugs, Chinese Herbal / chemistry. Drugs, Chinese Herbal / pharmacology. Female. Humans. Molecular Conformation. Plant Roots / chemistry. Rhizome / chemistry. Stereoisomerism. Vincristine / pharmacology

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Nat Prod. 1999 Nov;62(11):1479-83 [10579856.001]
  • [Cites] J Nat Prod. 2001 Jul;64(7):915-9 [11473423.001]
  • [Cites] J Nat Prod. 2006 Apr;69(4):695-9 [16643057.001]
  • [Cites] J Nat Prod. 2008 Apr;71(4):520-4 [18260639.001]
  • [Cites] Zhong Yao Cai. 2009 Apr;32(4):524-6 [19645238.001]
  • (PMID = 20073490.001).
  • [ISSN] 1520-6025
  • [Journal-full-title] Journal of natural products
  • [ISO-abbreviation] J. Nat. Prod.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA017625; United States / NCI NIH HHS / CA / R01 CA017625-32
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 0 / Drugs, Chinese Herbal; 0 / Sesquiterpenes; 5J49Q6B70F / Vincristine
  • [Other-IDs] NLM/ NIHMS171069; NLM/ PMC2829383
  •  go-up   go-down


6. Gupton JT, Burham BS, Krumpe K, Du K, Sikorski JA, Warren AE, Barnes CR, Hall IH: Synthesis and cytotoxicity of 2,4-disubstituted and 2,3,4-trisubstituted brominated pyrroles in murine and human cultured tumor cells. Arch Pharm (Weinheim); 2000 Jan;333(1):3-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nevertheless, activity with some of the derivatives occurred in the human KB nasopharynx, SW-480 colon, and HCT ileum adenocarcinoma, and lung A549 carcinoma screens.
  • De novo purine synthesis was retarded with the regulatory enzyme PRPP-amido transferase being markedly inhibited with less effects on the activities of IMP dehydrogenase, dihydrofolate reductase,, and the nucleoside kinases.
  • In vitro ct-DNA studies suggest that the agents may affect the DNA molecule itself with increased DNA viscosity and the Tmolt4 studies suggest that DNA cross-linking of DNA strands may be present.
  • [MeSH-major] Antineoplastic Agents / chemical synthesis. Hydrocarbons, Brominated / chemical synthesis. Pyrroles / chemical synthesis
  • [MeSH-minor] Cell Survival. DNA, Neoplasm / drug effects. Humans. Tumor Cells, Cultured

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 10675983.001).
  • [ISSN] 0365-6233
  • [Journal-full-title] Archiv der Pharmazie
  • [ISO-abbreviation] Arch. Pharm. (Weinheim)
  • [Language] eng
  • [Grant] United States / NCPDCID CDC HHS / CI / NCI-RISCA67236
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] GERMANY
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / DNA, Neoplasm; 0 / Hydrocarbons, Brominated; 0 / Pyrroles
  •  go-up   go-down


7. Mena-Rejon G, Caamal-Fuentes E, Cantillo-Ciau Z, Cedillo-Rivera R, Flores-Guido J, Moo-Puc R: In vitro cytotoxic activity of nine plants used in Mayan traditional medicine. J Ethnopharmacol; 2009 Jan 30;121(3):462-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vitro cytotoxic activity of nine plants used in Mayan traditional medicine.
  • ETHNOPHARMACOLOGICAL RELEVANCE: Plants have been used in folk medicine by Mayan ancient people from the Yucatan Peninsula, Mexico, to treat some diseases considered as cancer diseases such as chronic wounds or tumors.
  • MATERIALS AND METHODS: Methanolic extracts were tested for their cytotoxicity using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay on four cancer cell lines; nasopharynx carcinoma (KB), laryngeal carcinoma (Hep-2), cervix adenocarcinoma (HeLa), and cervix squamous carcinoma cells (SiHa) and one normal cell line; canine kidney (MDCK).
  • CONCLUSIONS: Hamelia patens, Dioon spinulosum and Gossypium schottii demonstrated promising cytotoxic activity and have been selected for future bio-guided fractionation and isolation of active cytotoxic compounds.
  • [MeSH-major] Angiosperms. Cytotoxins / therapeutic use. Neoplasms / drug therapy. Phytotherapy. Plant Extracts / therapeutic use
  • [MeSH-minor] Animals. Cell Line, Tumor. Dogs. Female. Humans. Indians, North American. Medicine, Traditional. Mexico. Plants, Medicinal

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Herbal Medicine.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19071205.001).
  • [ISSN] 1872-7573
  • [Journal-full-title] Journal of ethnopharmacology
  • [ISO-abbreviation] J Ethnopharmacol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Cytotoxins; 0 / Plant Extracts
  •  go-up   go-down


8. Kubota A, Furukawa M, Kawano T, Komatsu M: [Nedaplatin for recurrent cancer of the head and neck]. Nihon Jibiinkoka Gakkai Kaiho; 2004 May;107(5):475-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thirty-two patients, previously treated, (30 men and 2 women, mean age 59 years, twenty one with loco-regional recurrence and 11 with distant metastasis, 29 with squamous cell carcinoma, 2 with adenocarcinoma and one with adenoid cystic carcinoma) were treated with Nedaplatin (254-S) alone or combined with UFT.
  • The primary site was identified in the oropharynx in 8 patients, oral cavity in 7, larynx in 5, nasopharynx in 4, hypopharynx in 3, sinuses in one, parotid in one, and unknown primary in one patient.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Head and Neck Neoplasms / drug therapy. Organoplatinum Compounds / therapeutic use
  • [MeSH-minor] Adenocarcinoma / drug therapy. Adult. Aged. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Carcinoma, Adenoid Cystic / drug therapy. Carcinoma, Squamous Cell / drug therapy. Female. Humans. Male. Middle Aged. Survival Rate. Tegafur / administration & dosage. Uracil / administration & dosage

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15198007.001).
  • [ISSN] 0030-6622
  • [Journal-full-title] Nihon Jibiinkoka Gakkai kaiho
  • [ISO-abbreviation] Nippon Jibiinkoka Gakkai Kaiho
  • [Language] jpn
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Organoplatinum Compounds; 1548R74NSZ / Tegafur; 56HH86ZVCT / Uracil; 8UQ3W6JXAN / nedaplatin; 1-UFT protocol
  •  go-up   go-down


9. Roy K, Pal DK, De AU, Sengupta C: QSAR of antineoplastics IV: Hansch analysis of N-(7-indolyl)benzenesulfonamides against KB human nasopharynx carcinoma, colon 38 murine adenocarcinoma and P388 murine leukemia cell lines. Drug Des Discov; 2001;17(3):199-206
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] QSAR of antineoplastics IV: Hansch analysis of N-(7-indolyl)benzenesulfonamides against KB human nasopharynx carcinoma, colon 38 murine adenocarcinoma and P388 murine leukemia cell lines.
  • Hansch analysis of recently reported antitumor activities of novel N-(7-indolyl)benzenesulfonamide derivatives against KB human nasopharynx carcinoma, colon 38 murine adenocarcinoma and P388 murine leukemia cell lines reveals that the pattern of receptor interactions in human KB cells differs from that in murine (colon 38 and P388 leukemia) cells.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Agents / pharmacology. Colonic Neoplasms / drug therapy. Leukemia P388 / drug therapy. Nasopharyngeal Neoplasms / drug therapy. Sulfonamides / pharmacology
  • [MeSH-minor] Animals. Humans. KB Cells. Mice. Quantitative Structure-Activity Relationship. Tumor Cells, Cultured

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11469750.001).
  • [ISSN] 1055-9612
  • [Journal-full-title] Drug design and discovery
  • [ISO-abbreviation] Drug Des Discov
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Sulfonamides; 98-10-2 / benzenesulfonamide
  •  go-up   go-down


10. Cheng HH, Wang HK, Ito J, Bastow KF, Tachibana Y, Nakanishi Y, Xu Z, Luo TY, Lee KH: Cytotoxic pheophorbide-related compounds from Clerodendrum calamitosum and C. cyrtophyllum. J Nat Prod; 2001 Jul;64(7):915-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Compounds 1 and 6 were isolated for the first time as naturally occurring products from a plant source.
  • Biological evaluation showed that 1 and 2 exhibited strong cytotoxicity against human lung carcinoma (A549), ileocecal carcinoma (HCT-8), kidney carcinoma (CAKI-1), breast adenocarcinoma (MCF-7), malignant melanoma (SK-MEL-2), ovarian carcinoma (1A9), and epidermoid carcinoma of the nasopharynx (KB), and its etoposide- (KB-7d), vincristine- (KB-VCR), and camptothecin-resistant (KB-CPT) subclones.
  • Compounds 4-6, the methyl esters of 1-3, showed strongly increased cytotoxicity compared with the parent acids.
  • [MeSH-major] Antineoplastic Agents, Phytogenic / isolation & purification. Chlorophyll / isolation & purification. Plants, Medicinal / chemistry
  • [MeSH-minor] Adenocarcinoma / metabolism. Breast Neoplasms / metabolism. Camptothecin / metabolism. Camptothecin / pharmacology. Cell Survival / drug effects. Dose-Response Relationship, Drug. Drug Resistance. Etoposide / metabolism. Etoposide / pharmacology. Female. Humans. Ileal Neoplasms / metabolism. KB Cells / metabolism. Kidney Neoplasms / metabolism. Lung Neoplasms / metabolism. Magnetic Resonance Spectroscopy. Melanoma / metabolism. Molecular Structure. Ovarian Neoplasms / metabolism. Plant Leaves / chemistry. Plant Stems / chemistry. Stereoisomerism. Structure-Activity Relationship. Taiwan. Tumor Cells, Cultured / drug effects. Vincristine / metabolism. Vincristine / pharmacology

  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. VINCRISTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 11473423.001).
  • [ISSN] 0163-3864
  • [Journal-full-title] Journal of natural products
  • [ISO-abbreviation] J. Nat. Prod.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA-17625
  • [Publication-type] Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Phytogenic; 1406-65-1 / Chlorophyll; 15664-29-6 / pheophorbide a; 5J49Q6B70F / Vincristine; 6PLQ3CP4P3 / Etoposide; XT3Z54Z28A / Camptothecin
  •  go-up   go-down


11. Kennedy MT, Jordan RC, Berean KW, Perez-OrdoƱez B: Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol; 2004 Sep;57(9):932-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
  • BACKGROUND: Intestinal-type sinonasal adenocarcinoma (ITAC) is an uncommon neoplasm, which resembles adenocarcinoma of the gastrointestinal tract.
  • ITAC occurs sporadically or in association with occupational exposure to hardwood dust and other agents.
  • RESULTS: The diagnosis of ITAC was confirmed in 10 cases: five were colonic type and five were papillary.
  • One was a sinonasal papillary low grade adenocarcinoma, and one a papillary nasopharyngeal adenocarcinoma, and these tumours were CK7 positive, but CK20, CDX-2, and villin negative.
  • The expression pattern of CK7, CK20, CDX-2, and villin positive may be useful in separating these tumours from other non-ITAC adenocarcinomas of the sinonasal tract and nasopharynx.
  • [MeSH-major] Adenocarcinoma / chemistry. Biomarkers, Tumor / analysis. Intestinal Neoplasms / chemistry. Keratins / analysis. Nose Neoplasms / chemistry. Paranasal Sinus Neoplasms / chemistry
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Carrier Proteins / analysis. Female. Homeodomain Proteins / analysis. Humans. Immunohistochemistry / methods. Industry. Intermediate Filament Proteins / analysis. Intestinal Mucosa / pathology. Keratin-20. Keratin-7. Male. Metaplasia. Microfilament Proteins / analysis. Middle Aged. Occupational Diseases / pathology. Trans-Activators. Wood

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gastric Cancer. 2001;4(4):185-91 [11846061.001]
  • [Cites] Mod Pathol. 2000 Sep;13(9):962-72 [11007036.001]
  • [Cites] J Gastroenterol. 2003;38(1):14-22 [12560917.001]
  • [Cites] Histopathology. 2003 Feb;42(2):137-40 [12558745.001]
  • [Cites] Am J Surg Pathol. 2003 Mar;27(3):303-10 [12604886.001]
  • [Cites] J Cell Sci. 2003 Apr 15;116(Pt 8):1429-36 [12640028.001]
  • [Cites] Int J Cancer. 2003 Jun 10;105(2):196-203 [12673679.001]
  • [Cites] Ann Diagn Pathol. 2003 Jun;7(3):154-9 [12808566.001]
  • [Cites] Head Neck. 2003 Sep;25(9):763-71 [12953313.001]
  • [Cites] Am J Surg Pathol. 2003 Oct;27(10):1390-1 [14508402.001]
  • [Cites] Hum Pathol. 2003 Nov;34(11):1101-7 [14652810.001]
  • [Cites] J Cancer Res Clin Oncol. 2004 Jan;130(1):29-36 [14615935.001]
  • [Cites] J Biol Chem. 2003 Dec 19;278(51):51549-56 [14525978.001]
  • [Cites] Laryngoscope. 1966 Apr;76(4):621-50 [5930356.001]
  • [Cites] Cancer. 1982 Jul 15;50(2):312-22 [7083137.001]
  • [Cites] Am J Surg Pathol. 1982 Dec;6(8):803-9 [7168462.001]
  • [Cites] Cancer. 1984 Sep 1;54(5):855-60 [6378358.001]
  • [Cites] Acta Otolaryngol. 1984 Sep-Oct;98(3-4):321-34 [6496064.001]
  • [Cites] Acta Otolaryngol. 1985 May-Jun;99(5-6):641-8 [4024915.001]
  • [Cites] Am J Surg Pathol. 1986 Mar;10(3):192-202 [3953940.001]
  • [Cites] Arch Otorhinolaryngol. 1988;245(1):1-15 [2839136.001]
  • [Cites] Am J Surg Pathol. 1988 Dec;12(12):946-53 [2462370.001]
  • [Cites] Pathol Res Pract. 1989 May;184(5):554-8 [2748468.001]
  • [Cites] Lab Invest. 1991 Mar;64(3):418-24 [2002658.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1991;248(4):222-9 [1859655.001]
  • [Cites] Mol Carcinog. 1998 Jul;22(3):182-9 [9688144.001]
  • [Cites] Biochem Cell Biol. 1998;76(6):957-69 [10392709.001]
  • [Cites] Mod Pathol. 1995 May;8(4):421-6 [7567943.001]
  • [Cites] Hum Pathol. 1999 Oct;30(10):1140-5 [10534159.001]
  • [Cites] Acta Otolaryngol. 2002 Mar;122(2):197-201 [11936913.001]
  • (PMID = 15333652.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Carrier Proteins; 0 / Homeodomain Proteins; 0 / Intermediate Filament Proteins; 0 / KRT20 protein, human; 0 / KRT7 protein, human; 0 / Keratin-20; 0 / Keratin-7; 0 / Microfilament Proteins; 0 / Trans-Activators; 0 / villin; 156560-97-3 / Cdx-2-3 protein; 68238-35-7 / Keratins
  • [Other-IDs] NLM/ PMC1770431
  •  go-up   go-down






Advertisement